Daniela Laranja Gomes Rodrigues

Ms. Daniela Laranja Gomes Rodrigues


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
GBGisele Silvestre Belber
Gisele Silvestre Belber
FPFrederica Valle De Queiroz Padilha
Frederica Valle De Queiroz Padilha
LSLigia Fonseca Spinel
Ligia Fonseca Spinel
FMFrederico Rafael Moreira
Frederico Rafael Moreira
ÁJÁlvaro Avezum Júnior
Álvaro Avezum Júnior
Background: Although the Brazilian Unified Health System (SUS) offers universal health coverage, access to quality care is often limited by social inequality and location. Although telemedicine has been shown to be an important tool in the efforts to overcome this problem, because it can provide access to specialist care and break the geographical barriers to health care, there are no national studies demonstrating its use in public health. Objective: This study aims to test the hypothesis that remote consultation can be as effective as standard face-to-face consultation for type 2 diabetes mellitus in the Brazilian public health system and to assess the associated costs related to teleconsultation in public health scenarios, for patients referred from Primary Health Care units of the SUS for specialist care. Methods: This is a pragmatic, phase 2, unicentric, open-label, noninferiority, blinded allocation, data-blinded, centrally randomized clinical trial. The inclusion criteria will be adults, both sexes, ≥18 years old, glycated hemoglobin (HbA1c) ≥8%. Outcomes will be evaluated by assessing symptoms, laboratory exams, anthropometric measurements, blood pressure, adverse events, and satisfaction level for 6 months. The costs of the teleconsultation will be assessed using the time-driven activity-based costing (TDABC) method to compare the costs with the face-to-face consultations. The noninferiority margin was set at 0.5%. Assuming an SD of 1.3% for both groups, true difference between the means of zero, and a type I error level of 5% (one-sided), it was estimated that 117 individuals per group would be necessary to achieve 90% power. Statistical analysis of the efficacy will be done using intention-to-treat and per-protocol approaches. Results: The results from this trial will be reported according to the CONSORT guidelines. The trial was approved by the institutional review board on October 5, 2019. Data collection started in January 2019 and is expected to finish in 2022. At the time of manuscript submission, 18 participants were recruited. Conclusions: Our expectations are that providing remote access to health care will result in improvements in the health and quality of life of patients with type 2 diabetes and reduce costs and that both patients and clinicians will benefit from and be satisfied with this technology. Trial Registration: Registro Brasileiro de Ensaios Clínicos RBR-8gpgyd; https://ensaiosclinicos.gov.br/rg/RBR-8gpgyd International Registered Report Identifier (IRRID): DERR1-10.2196/23679


21 February 2024 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
FPFrederica Valle de Queiroz Padilha
Frederica Valle de Queiroz Padilha
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
GBGisele Silvestre Belber
Gisele Silvestre Belber
MMMarcos Aurélio Maeyama
Marcos Aurélio Maeyama
LSLígia Spinel
Lígia Spinel
HJHaliton Oliveira Junior
Haliton Oliveira Junior
OBJETIVO: Apresentar os resultados da análise de custos para a modalidade de consulta remota (teleconsulta) em comparação à consulta presencial, em pacientes com diabetes do tipo 2, no Sistema Único de Saúde (SUS) brasileiro, na cidade Joinville, Santa Catarina. Para além dos custos, sob a perspectiva do gestor local, o artigo também apresenta estimativas sob perspectiva do paciente, a partir dos custos de transporte associados a cada modalidade de consulta. MÉTODO: Foram coletados dados de 246 consultas, remotas e presenciais, entre 2021 e 2023, no contexto de um ensaio clínico randomizado sobre o impacto da teleconsulta realizado na cidade de Joinville, SC. As teleconsultas foram realizadas em Unidades Básicas de Saúde (UBS) e as consultas presenciais no Centro de Saúde Especializada. Para o cálculo dos custos, foi utilizado o método de custos baseado em tempo e atividade (TDABC) e, para o cálculo dos custos relativos aos transportes dos pacientes, foram coletados dados diretamente com os participantes da pesquisa. Foram analisados e comparados descritivamente os custos médios e o tempo de realização de cada modalidade de consulta em diferentes cenários e perspectivas. RESULTADOS: Considerando apenas a perspectiva do gestor local do SUS, os custos para a realização da teleconsulta se mostraram 4,5% maiores do que para uma consulta presencial. Contudo, quando considerados os custos de transporte associados a cada paciente, o valor estimado da consulta presencial passa a ser 7,7% maior e, no caso de consultas em outros municípios, 15% maior do que a teleconsulta. CONCLUSÃO: Os resultados demonstram que a incorporação da teleconsulta dentro do SUS pode trazer vantagens econômicas, a depender da perspectiva e do cenário considerado, além de ser uma estratégia com potencial para aumentar o acesso à atenção especializada na rede pública.

23 October 2024 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
GBGisele Silvestre Belber
Gisele Silvestre Belber
FPFrederica Valle de Queiroz Padilha
Frederica Valle de Queiroz Padilha
LALucas Bassolli de Oliveira Alves
Lucas Bassolli de Oliveira Alves
ÁAÁlvaro Avezum
Álvaro Avezum
HJHaliton Alves de Oliveira Junior
Haliton Alves de Oliveira Junior
Background This study addresses the rising burden of type 2 diabetes mellitus, and explores the potential of teleconsultation, as an alternative for diabetes management. The primary objective was to test the hypothesis that teleconsultation is non-inferior to face-to-face consultation in terms of glycaemic control measured as glycated haemoglobin (HbA1c) (non-inferiority margin for the upper confidence interval for the difference between groups of 0,5% in HbA1c) for type 2 diabetes mellitus patients referred from Primary Healthcare to Specialized Care within the SUS. Methods TELECONSULTA, is a randomized, pragmatic, phase 2, single-centre, open-label, non-inferiority trial conducted in Joinville, Brazil. A total of 278 participants diagnosed with type 2 diabetes were randomized through mandatory teleconsulting services from primary care health units. The randomization was 1:1 to teleconsultation or face to face consultation. The study was registered at the Brazilian Clinical Trial Register-REBEC, under the code RBR-8gpgyd. Study status is " Completed " . Findings This study included 278 participants in the intention-to-treat (ITT) analysis. The median age was 61 (54-68) years, 167 (60%) were women. The between-groups comparative average reduction in HbA1c was - 0.6% (90% CI - 1.0; - 0.1) at 3-months and - 0.5% (90% CI - 0.9; 0.0) at 6-months in Modified Intention-to-Treat (mITT) population with imputed data, showing the non-inferiority of teleconsultation. Results with no missing data imputation and in the per protocol population were similar. The frequency of hypoglycaemia and other adverse events was well balanced between groups. Interpretation The results underscore the transformative potential of telemedicine in addressing the complexities of diabetes management within the framework of a universal healthcare system, contributing with valuable insights for healthcare policymakers and practitioners seeking innovative solutions to tackle the growing diabetes epidemic.

4 February 2025 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
MFMelina Alves da Frota
Melina Alves da Frota
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
MMMarcos Aurélio Maeyama
Marcos Aurélio Maeyama
FPFrederica Padilha
Frederica Padilha
FHFernanda Saks Hahne
Fernanda Saks Hahne
Background Telemedicine, a patient-centered approach that leverages technology, has emerged as a cost-effective solution to provide comprehensive medical services for acute and chronic conditions. Objective We aim to document the experiences of pediatric neurologists using teleconsultations within the TeleNortheast program, a specialized medical assistance initiative in the Northeast of Brazil. Methods A retrospective analysis of teleconsultations was conducted from January to October 2023. Data from 546 teleconsultations, involving 506 pediatric patients, were extracted from medical records. Consultations were conducted between pediatric neurologists in São Paulo and primary care professionals in Sergipe. The analysis included patients' demographics, diagnoses, and outcomes. Results Of the 506 teleconsultation patients seen, 89% continued treatment within their primary care settings without needing in-person referrals. Discharge was observed in 9.5% of cases, and only 1.4% required specialized in-person care. The most frequent diagnosis was autism spectrum disorder (19.1%), followed by epilepsy (7.1%), attention-deficit/hyperactivity disorder (6.7%), and intellectual disability (5.9%). A cost-saving analysis indicated that teleconsultations avoided significant transportation costs, which could reach up to R$ 21 thousand for travel and feeding expenses. Conclusion The results highlight the effectiveness of teleconsultations in improving access to pediatric neurological care in underserved regions, reducing the need for in-person counseling, with the potential to provide significant cost savings for the public health system. The TeleNortheast program demonstrates the potential of this approach to bridge healthcare gaps, particularly in regions with limited access to specialized care.

21 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
EAEmanuelle Roberta da Silva Aquino
Emanuelle Roberta da Silva Aquino
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
CBCarlos Eduardo Alves Batista
Carlos Eduardo Alves Batista
JBJosue Basso
Josue Basso
SGSabrina Dalbosco Gadenz
Sabrina Dalbosco Gadenz
CMCarlos Eduardo Mantese
Carlos Eduardo Mantese
OBJECTIVE: This study aimed to characterize teleconsultations in neurology executed by Regula+Brasil project in Recife, a capital city in northeastern Brazil. METHODS: A descriptive study carried out by four private hospitals, in a partnership with the Ministry of Health in Brazil. Teleconsultation was performed preferably in the video modality. Conditions eligible for teleconsultation were headache, epilepsy, and cerebrovascular disorders. Period of analysis was May to September 2020. RESULTS: A total of 243 teleconsultations were analyzed, of which 76.95% was a first appointment. In 48.97% of cases, the teleconsultation represented the first opportunity for the patient to be consulted with the specialist. Among cases of first appointment, 20.16% were further referred to a face-to-face consultation and 21.81% could be redirected to primary health care. Headache disorders were the most predominant clinical conditions. CONCLUSIONS: The implementation and development of telemedicine by Regula+Brasil during the COVID-19 pandemic represented an opportunity to assess the value of having teleconsultations added along the line of care from primary care to a medical specialty, promoting the coordination of care across different levels of complexity of care in the health system and improving access to specialized care. KEYWORDS: Neurology. Referrals and consultation. Effective access to health services. Public Health.